logo
Select company
Select metric
$ 74.1MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
82
Sector
89
Industry
92
History
78
$ 3.77Close
$ 0.98 - $ 4.15 52-Week Range
Ticker Information

Ticker

EDIT

Company Name

EDITAS MEDICINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

EDITAS MEDICINE INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

EDIT - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 74.1M
3/31/2025$ 69.47M
12/31/2024$ 7.89M
9/30/2024$ 13.29M
6/30/2024$ -156.38M
3/31/2024$ -59.79M
12/31/2023$ -17.87M
9/30/2023$ -128.17M
6/30/2023$ 51.42M
3/31/2023$ -81.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • EDITAS MEDICINE INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 177.06M.
  • Over the past 5 years, EDITAS MEDICINE INC's average CF - Chg. Cash has been $ -27.55M.
  • The median CF - Chg. Cash for EDITAS MEDICINE INC during this period was $ -34.44M
  • EDITAS MEDICINE INC reached its highest CF - Chg. Cash over the past 5 years at $ 177.06M.
  • The lowest CF - Chg. Cash recorded by EDITAS MEDICINE INC in the same timeframe $ -168.43M

EDITAS MEDICINE INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
CCCC : C4 THERAPEUTICS INC $ 5.04MVYGR : VOYAGER THERAPEUTICS INC $ -32.19MFENC : FENNEC PHARMACEUTICALS INC $ -24.35MOABI : OMNIAB INC $ -2.51MSCPH : SCPHARMACEUTICALS INC $ 2.31MSPRO : SPERO THERAPEUTICS INC $ -32.33MCELU : CELULARITY INC $ 382KTKNO : ALPHA TEKNOVA INC $ -15.32MUTMD : UTAH MEDICAL PRODUCTS INC $ -7.04MIVVD : INVIVYD INC $ -112.98M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

EDIT - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -168.43M

Minimum

Jun 30, 2022

$ 177.06M

Maximum

Sep 30, 2020

$ -27.55M

Average

$ -34.44M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M